Tranexamic Acid for Hyperfibrinolytic Hemorrhage During Conservative Management of Placenta Percreta

Abstract

Isolated hyperfibrinolysis is a potential cause of bleeding during conservative management of placenta increta and percreta. Management of this treatment approach should include hemostasis monitoring, because hyperfibrinolysis can be successfully controlled using fibrinolysis inhibitors.